Last reviewed 2026-05-21 · How we verify

Pf-08052666 (pf-08052666)

Pfizer · FDA-approved active Under review Quality 40/100

Pf-08052666 (generic name: pf-08052666) is a Small molecule inhibitor drug developed by Pfizer. It is currently FDA-approved (first approved Unkn) for Indication not found, Indication not found.

Pf-08052666 is a compound being studied in clinical trials for various types of cancer, including non-small-cell lung carcinoma, ovarian neoplasms, pancreatic adenocarcinoma, colorectal neoplasms, and mesothelioma. The exact mechanism of action of Pf-08052666 is currently unknown.

At a glance

Generic name	pf-08052666
Sponsor	Pfizer
Drug class	Small molecule inhibitor
Target	Specific protein involved in disease pathways
Therapeutic area	Other
Phase	FDA-approved
First approval	Unknown

Approved indications

Indication not found
Indication not found

Pipeline indications

Common side effects

No common side effects on file.

Drug interactions

Warfarin
Aspirin
Pentobarbital
Phenobarbital
Rivaroxaban
Apixaban
Dabigatran
Clopidogrel
Ticagrelor
Prasugrel
Cilostazol
Dipyridamole

Key clinical trials

A Study of SGN-MesoC2 in Advanced Solid Tumors (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
FDA label	Mechanism, indications, dosing, boxed warnings, drug interactions
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Pf-08052666 CI brief — competitive landscape report
Pf-08052666 updates RSS · CI watch RSS
Pfizer portfolio CI

Frequently asked questions about Pf-08052666

What is Pf-08052666?

Pf-08052666 (pf-08052666) is a Small molecule inhibitor drug developed by Pfizer, indicated for Indication not found, Indication not found.

What is Pf-08052666 used for?

Pf-08052666 is indicated for Indication not found, Indication not found.

Who makes Pf-08052666?

Pf-08052666 is developed and marketed by Pfizer (see full Pfizer pipeline at /company/pfizer).

What is the generic name of Pf-08052666?

pf-08052666 is the generic (nonproprietary) name of Pf-08052666.

What drug class is Pf-08052666 in?

Pf-08052666 belongs to the Small molecule inhibitor class. See all Small molecule inhibitor drugs at /class/small-molecule-inhibitor.

When was Pf-08052666 approved?

Pf-08052666 was first approved on Unknown.

What development phase is Pf-08052666 in?

Pf-08052666 is FDA-approved (marketed).

What does Pf-08052666 target?

Pf-08052666 targets Specific protein involved in disease pathways and is a Small molecule inhibitor.

Drug class: All Small molecule inhibitor drugs
Target: All drugs targeting Specific protein involved in disease pathways
Manufacturer: Pfizer — full pipeline
Therapeutic area: All drugs in Other
Indication: Drugs for Indication not found
Indication: Drugs for Indication not found

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing